Healthcare stocks jump after Republicans unveil plan; banks, staples slip
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Accenture plc (ACN) PT Raised to $130 at BMO Capital on 3Q Report; 'Story & Opportunity Remain Fairly Steady'
June 23, 2017 9:26 AM EDTBMO Capital raised its price target on Accenture plc (NYSE: ACN) to $130.00 (from $125.00) while maintaining a Market Perform rating, following the company's third quarter earnings report.
Analyst Keith Bachman notes the company delivered in-line third quarter earnings per share results, while offering revenues above... More
Oracle (ORCL) PT Raised to $56 at Canaccord Genuity on 4Q Beat; 'Expects PaaS & IaaS Business to Enter Hyper-Growth in F18'
June 22, 2017 10:58 AM EDTCanaccord Genuity raised its price target on Oracle (NYSE: ORCL) to $56.00 (from $49.00) while maintaining a Buy rating, following the company's fourth quarter earnings announcement.
Analyst Richard Davis notes the company delivered fourth quarter earnings per share, revenues and margins above consensus projections... More
Oracle (ORCL) PT Raised to $52 at UBS Following 4Q
June 22, 2017 9:18 AM EDTUBS raised its price target on Oracle (NYSE: ORCL) to $52.00 (from $48.00) while maintaining a Buy rating following the company's 4Q earnings report.
The standout highlights from ORCL's 4Q was the $500M revenue beat and +200bps of margin upside, which combined delivered ~7c of EPS outperformance.
... MoreOracle (ORCL) PT Raised to $57 at BMO Capital on 4Q Beat; 'Strong Performance was Broadly Based'
June 22, 2017 8:58 AM EDTBMO Capital raised its price target on Oracle (NYSE: ORCL) to $57.00 (from $48.00) while maintaining a Outperform rating, following the company's fourth quarter announcement.
Analyst Keith Bachman notes the company delivered fourth quarter earnings per share, revenues and operating margins above consensus projections... More
Oracle (ORCL) PT Raised to $48 at Deutsche Bank Following 4Q
June 22, 2017 7:39 AM EDTDeutsche Bank raised its price target on Oracle (NYSE: ORCL) to $48.00 (from $44.00) while maintaining a Hold rating.... More
